1. Introduction {#sec1-molecules-21-01139}
===============

Bile acids, such as deoxycholic (**1**), chenodeoxycholic (**2**), cholic (**3**) and hyodeoxycholic (**4**) ([Figure 1](#molecules-21-01139-f001){ref-type="fig"}), have been used as substrates for the synthesis of a large number of brassinosteroid analogues, keeping the methyl ester or carboxylic function in the side chain \[[@B1-molecules-21-01139],[@B2-molecules-21-01139],[@B3-molecules-21-01139],[@B4-molecules-21-01139],[@B5-molecules-21-01139],[@B6-molecules-21-01139],[@B7-molecules-21-01139]\]. In particular, hyodeoxycholic acid (**4**) has been used because it contains the modifiable organic functions at suitable positions, satisfying the structural requirements on the A and/or B and A/B *trans* fusion ring and side chain of active brassinosteroids \[[@B8-molecules-21-01139],[@B9-molecules-21-01139],[@B10-molecules-21-01139],[@B11-molecules-21-01139],[@B12-molecules-21-01139],[@B13-molecules-21-01139],[@B14-molecules-21-01139],[@B15-molecules-21-01139],[@B16-molecules-21-01139],[@B17-molecules-21-01139],[@B18-molecules-21-01139],[@B19-molecules-21-01139],[@B20-molecules-21-01139],[@B21-molecules-21-01139],[@B22-molecules-21-01139],[@B23-molecules-21-01139],[@B24-molecules-21-01139],[@B25-molecules-21-01139],[@B26-molecules-21-01139]\]. Hyodeoxycholic acid (HDA) extracted from hog bile was initially used as a precursor for steroid synthesis \[[@B27-molecules-21-01139]\]. It has also been shown that HDA prevents cholesterol-induced gallstones in animals fed with a lithogenic diet \[[@B28-molecules-21-01139]\], whereas oral administration of HDA leads to a decrease in the LDL-cholesterol concentration, a strong stimulation of hepatic cholesterol biosynthesis and an excessive loss of cholesterol in feces \[[@B29-molecules-21-01139]\].

In this work, we report an improved synthesis route to obtain known brassinosteroid analogues, starting from hyodeoxycholic acid (**4**), and maintaining the native side chain. Additionally, the full NMR spectroscopic characterization of these derivatives is performed.

2. Results and Discussion {#sec2-molecules-21-01139}
=========================

Fischer esterification of hyodeoxycholic acid (**4**) with the H~2~SO~4~-MeOH system gave the methyl hyodeoxycholate (**5**) in almost quantitative yield (98%). Subsequently, selective oxidation of the C-6 hydroxyl group with PCC/CH~2~Cl~2~ afforded the di- and mono-oxidized compounds **6** and **7** with 30% and 68% yield, respectively. These yields are similar to those reported when PDC/CH~2~Cl~2~ was the oxidizing agent \[[@B13-molecules-21-01139]\]. However, the yield of compound **7** was 67%--70% when K~2~CrO~4~ was used as an oxidizing agent \[[@B30-molecules-21-01139],[@B31-molecules-21-01139]\]. Thus, in order to increase the yield of this reaction, **6** was conveniently converted to the desired monoketone **7** by selective reduction with NaBH~4~/MeOH at a low temperature (0--5 °C) with 96.8% yield ([Scheme 1](#molecules-21-01139-sch001){ref-type="scheme"}). This reaction has been used to modify steroids with similar structures \[[@B24-molecules-21-01139]\]. The overall yield of **7** is increased from 68% to 96.8%. The physical properties and spectroscopic data (IR and ^1^H-NMR) of compounds **6** and **7** were consistent with those previously reported \[[@B8-molecules-21-01139],[@B30-molecules-21-01139],[@B31-molecules-21-01139],[@B32-molecules-21-01139]\]. The ^13^C-NMR spectroscopic data for compound **7** has been informed but not assigned \[[@B32-molecules-21-01139]\].

Compound **7** was readily isomerized (94.4% yield) under acid conditions (2.5% HCl/MeOH) to give the derivative **8** possessing 5α-cholestan-6-one skeleton \[[@B8-molecules-21-01139],[@B13-molecules-21-01139],[@B32-molecules-21-01139]\]. This isomerization reaction can be performed under alkaline conditions as well, but under these conditions the obtained compound was isomerized and hydrolyzed (carboxylic acid) with 84% yield \[[@B31-molecules-21-01139]\]. Thus, to get **8**, an additional esterification reaction was carried out with 94% yield. The physical properties, IR, and ^1^H-NMR spectroscopic data of compound **8** have been previously reported, but the signals of ^13^C-NMR were not assigned \[[@B32-molecules-21-01139]\]. The change of the 5β-cholestan to 5α-cholestan skeleton (A/B ring *cis* for *trans* fusion) implies a very important structural modification, and therefore a detailed analysis of NMR spectroscopic data for compounds **7** and **8** must be performed. The main differences found in the ^1^H- and ^13^C-NMR data are shown in [Figure 2](#molecules-21-01139-f002){ref-type="fig"}. The signals corresponding to H-3β and H-5α (δ~H~ = 4.16 and δ~H~ = 2.70 ppm, respectively) in compound **8**, are displaced to downfield as compared to compound **7** (δ~H~ = 3.62 and δ~H-5β~ = 2.33 ppm, respectively). On the other hand, the signal of CH~3~-19 in the ^13^C-NMR of compound **8** appears at a higher field (δ~C~ = 12.29 ppm) than in the spectrum of compound **7** (δ~C~ = 23.16 ppm).

The reaction of compound **8** with methanesulfonyl chloride (mesyl chloride) in CH~2~Cl~2~/DMAP produces the mesylated derivative **9** with 61% yield \[[@B28-molecules-21-01139]\]. The major ^1^H-NMR spectroscopic evidence for formation of this derivative is the presence of signals at δ~H~ = 5.02 and 2.97 ppm assigned to hydrogen H-3β (b.s. 1H) and CH~3~-SO~2~- (s, 3H), respectively, whereas in the ^13^C-NMR spectrum, a signal corresponding to CH~3~-SO~2~ was observed at δ~C~ = 38.38 ppm. Subsequent treatment of compound **9** with the Li~2~CO~3~/LiBr system at 80 °C in dimethylformamide (DMF) produces the alquene **10** with 74.9% yield \[[@B33-molecules-21-01139]\] ([Scheme 2](#molecules-21-01139-sch002){ref-type="scheme"}). The ^1^H-NMR spectroscopic data of alquene **10** was consistent with that previously reported \[[@B8-molecules-21-01139],[@B32-molecules-21-01139]\]. Additionally, in the ^13^C-NMR spectrum the signals at δ~C~ = 124.49 (C-2) and 124.95 (C-3) ppm are observed. Both signals were assigned from the 2D HMBC spectrum, where the H-3 (δ~H~ = 5.69--5.66 ppm, m, 1H) showed ^3^*J*~H-C~ correlation with C-1 (δ~C~ = 39.34 ppm) and ^2^*J*~H-C~ with C-4 (δ~C~ = 27.88 ppm), while H-2 (δ~H~ = 5.57--5.55 ppm, m, 1H) showed ^3^*J*~H-C~ correlation with C-4 (δ~C~ = 27.88 ppm) and ^2^*J*~H-C~ with C-1 (δ~C~ = 39.34 ppm).

Compound **11** was obtained with 51% yield by stereospecific α-face hydroxylation of olefin **10** using a catalytic amount of osmium tetraoxide (4.0%) in a mixture of (CH~3~)~2~CO-H~2~O (3:1) and 2.0 mL of pyridine, and in the presence of *N*-methylmorpholine *N*-oxide \[[@B33-molecules-21-01139]\]. The ^1^H- and ^13^C-NMR spectroscopic data of diol **11** were consistent with those reported \[[@B8-molecules-21-01139],[@B32-molecules-21-01139]\]. In addition, the spatial orientations of α-OH in C-2 and α-OH in C-3 were determined by selective-excitation 1D NOESY experiments, where H-2β (3.77 ppm, b.d, *J* = 11.1 Hz, 1H) showed a long-range spatial correlation with CH~3~-19 (0.75 ppm, s, 3H), while the observed signals at δ~C~ = 68.29 and 68.39 ppm in the ^13^C-NMR spectrum were assigned to C-2 and C-3, respectively.

In order to get additional deoxycholic acid derivatives, which may be of interest, the chemical transformations described in [Scheme 2](#molecules-21-01139-sch002){ref-type="scheme"} were performed. Thus, compound **8** was acetylated under standard conditions (Ac~2~O/DMAP/CH~2~Cl~2~), and commercial compound **12** was obtained with 95% yield. The synthesis of this derivative has been previously reported, but no NMR spectroscopic data was included \[[@B25-molecules-21-01139]\]. The ^1^H-NMR spectrum of the acetylated derivative **12** shows a singlet at δ~H~ = 2.04 ppm (3H, CH~3~CO) and a multiplet at δ~H~ = 5.12 ppm corresponding to H-3β (m, 1H). The latter is shifted to downfield as compared with H-3β (δ~H~ = 4.16 ppm, m 1H) in compound **8**. Additionally, in the ^13^C-NMR spectrum the signals appearing at δ~C~ = 170.31 (C=O) and 21.39 (CH~3~CO) ppm ([Table 1](#molecules-21-01139-t001){ref-type="table"}) confirmed the presence of acetylated derivative **12**.

The synthesis of compound **13** by saponification of **8** with NaOH/dioxane under reflux conditions has been previously informed \[[@B31-molecules-21-01139]\]. Saponification of compound **8** under mild conditions (K~2~CO~3~/MeOH, reflux) produces the carboxylic acid **13** with similar yields (82.2% yield) ([Scheme 2](#molecules-21-01139-sch002){ref-type="scheme"}). The physical property data, IR and ^1^H-NMR were consistent with those reported \[[@B31-molecules-21-01139]\]. The ^13^C-NMR spectrum shows a signal at δ~C~ = 178.19 ppm (C=O) ([Table 1](#molecules-21-01139-t001){ref-type="table"}), confirming the presence of the carboxylic function. Standard acetylation (Ac~2~O/DMAP/CH~2~Cl~2~) of **13** produces compound **14** with 72.8% yield. Compound **14** showed signals at 3373--2495 (OH), 1736 (C=O) and 1708 (C=O) cm^−1^ in the IR spectrum, while in ^1^H-NMR the signals observed at δ~H~ = 5.12 ppm (m, 1H) and 2.03 ppm (s, 3H) were assigned to the H-3β and CH~3~CO, respectively. In the ^13^C-NMR spectrum the observed signals at δ~C~ = 170.33 and 21.41 ppm ([Table 1](#molecules-21-01139-t001){ref-type="table"}) were assigned to the acetyl group, while the signal at δ~C~ = 179.20 ppm ([Table 1](#molecules-21-01139-t001){ref-type="table"}) was assigned to the carboxylic function. These spectroscopic data confirmed the structure of compound **14**.

The Baeyer-Villiger oxidation of 3α-hydroxy-6-oxo-5α-cholanate **8** with *m*-CPBA/CH~2~Cl~2~ gave a mixture of known 7-oxalactone **15** and 6-oxalactone **16** with 10.8% and 14.9% yields, respectively. The physical and IR, ^1^H-NMR spectroscopic data of **15** and **16** were consistent with those reported for these compounds \[[@B14-molecules-21-01139],[@B25-molecules-21-01139]\]. Considering that the original ^1^H-NMR spectra were recorded with a 60 MHz spectrometer, and no ^13^C-NMR data was reported, we believe that it is worth updating the analysis of NMR data for these compounds.

The full structural assignment of compound **15** and in particular the 7-oxalactone position was mainly assigned by ^1^H, ^13^C, 2D HSQC and 2D HMBC NMR spectroscopy. In the ^1^H-NMR spectrum of compound **15** appears a signal at δ~H~ = 4.08--4.06 ppm (m, 2H), which was assigned to the two hydrogens H-7 and correlated by 2D ^1^H-^13^C HSQC with the signal δ~C~ = 70.44 ppm (C-7) with pair multiplicity (from DEPT-135 analysis). Additionally, from the 2D ^1^H-^13^C HMBC spectrum important heteronuclear correlations were observed, i.e., ^2^*J*~HC~ correlations between H-5α (δ~H~ = 3.17 ppm, dd, *J* = 4.4 and 12.2 Hz) with the signals at δ~C~ = 176.76 (C=O of lactone function), δ~C~ = 36.29 and δ~C~ = 30.81 ppm which were assigned to the carbons C-6, quaternary C-10 and C-4, respectively. Additionally, H-5α showed ^3^*J*~HC~ correlation with signals at δ~C~ = 30.81, δ~C~ = 14.52, δ~C~ = 32.88 and δ~C~ = 58.35 ppm, which were assigned to the carbons C-4, CH~3~-19, C-1 and C-9, respectively ([Figure 3](#molecules-21-01139-f003){ref-type="fig"}a). These 2D HMBC observations unequivocally confirm the 7-oxalactone position for compound **15**.

A similar analysis was performed for the structure determination of 6-oxolactone **16**; thus, in the ^1^H-NMR spectrum for **16** a signal at δ~H~ = 4.60 ppm (dd, 1H, *J* = 5.3 and 11.3 Hz) was observed, correlated by 2D ^1^H-^13^C HSQC with the signal at δ~C~ = 79.65 ppm (C-7) with impair multiplicity (from DEPT-135 analysis) and assigned to H-5α. Additionally, H-5 α showed ^2^*J*~HC~ correlation with signals at δ~C~ = 35.63 ppm and ^3^*J*~HC~ correlation with signals at δ~C~ = 11.53, δ~C~ = 57.97 and δ~C~ = 175.35 ppm, which were assigned to the carbons C-4, CH~3~-19, C-9 and C-6 (C=O, of lactone function), respectively ([Figure 3](#molecules-21-01139-f003){ref-type="fig"}b).

3. Materials and Methods {#sec3-molecules-21-01139}
========================

3.1. General {#sec3dot1-molecules-21-01139}
------------

All reagents were purchased from commercial suppliers (Merck, Darmstadt, Germany or Aldrich, St. Louis, MO, USA), and used without further purification. Melting points were measured on a Stuart-Scientific SMP3 apparatus (Staffordshire, UK) and are uncorrected. ^1^H, ^13^C, ^13^C DEPT-135, sel. gs1D ^1^H NOESY, gs 2D HSQC and gs 2D HMBC NMR spectra were recorded in CDCl~3~ or MeOD solutions, and are referenced to the residual peaks of CHCl~3~ at δ = 7.26 ppm and δ = 77.00 ppm for ^1^H and ^13^C, respectively and CD~3~OD at δ = 3.30 ppm and δ = 49.00 ppm for ^1^H and ^13^C, respectively, on a Bruker Avance 400 Digital NMR spectrometer (Bruker, Rheinstetten, Germany), operating at 400.1 MHz for ^1^H and 100.6 MHz for ^13^C. Chemical shifts are reported in δ ppm and coupling constants (*J*) are given in Hz. IR spectra were recorded as KBr disks in a FT-IR Nicolet 6700 spectrometer (Thermo Scientific, San Jose, CA, USA) and frequencies are reported in cm^−1^. For analytical TLC, silica gel 60 (Merck) in 0.25 mm layer was used and TLC spots were detected by heating after spraying with 25% H~2~SO~4~ in H~2~O. Chromatographic separations were carried out by conventional column on silica gel 60 (230--400 mesh, Merck) using EtOAc-hexane gradients of increasing polarity. All organic extracts were dried over anhydrous magnesium sulfate and evaporated under reduced pressure, below 40 °C.

3.2. Synthesis {#sec3dot2-molecules-21-01139}
--------------

*Methyl 3α, 6α-dihydroxy-5β-cholan-24-oate* (**5**). A solution of **4** (20.0 g, 50.95 mmol) in MeOH (150 mL) and 1.0 mL of H~2~SO~4~ was refluxed for 2.0 h. The end of reaction was verified by TLC. Then the solvent was removed (until a 40 mL approximate volume) and diluted with EtOAc (90 mL). The organic layer was washed with saturated solution of NaHCO~3~ (40 mL) and water (2 × 30 mL), dried over Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure. The crude was re-dissolved in CH~2~Cl~2~ (15 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 7.6:2.4). Compound **5** (19.50 g 98% yield) was a colorless solid (m.p. = 60--65 °C, MeOH/Et~2~O); IR (cm^−1^): 3385 (O-H); 2938 (C-CH~3~); 2858 (C-CH~2~-C); 1743 (C=O); 1452 (CH~2~); 1376 (CH~3~); 1169 (C-O). ^1^H-NMR: 4.05 (ddd, *J* = 4.8, 4.8 and 11.9 Hz, 1 H, H-6); 3.66 (s, 3H, CH~3~O); 3.62 (m, 1H, H-3); 2.35 (ddd, *J* = 5.1, 10.1 and 15.0 Hz, 1H, H-23); 2.21 (ddd, *J* = 6.6, 9.6 and 15 Hz, 1H, H-23); 0.91 (d, *J* = 5.1 Hz, 3H, H-21); 0.90 (s, 3H, H-19); 0.63 (s, 3H, H-18). ^13^C-NMR: See [Table 2](#molecules-21-01139-t002){ref-type="table"}.

*Methyl 3, 6-dioxo-5β-cholan-24-oate* (**6**) and *Methyl 3α-hydroxy-6-oxo-5β-cholan-24-oate* (**7**). To a solution of **5** (16.50 g, 40.58 mmol) in DCM (100 mL), 8.75 g, (40.58 mmol) of PCC in 60 mL of DCM, were added by slow dripping. The reaction mixture was slowly stirred for 48 h at room temperature and the end of reaction was verified by TLC, filtered on silica (pore size 60 Å, 220--440 mesh) with DCM 30 mL. The solvent was evaporated under reduced pressure and the crude was re-dissolved in CH~2~Cl~2~ (5 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 5.8:4.2). Two fractions were obtained: Fraction I, 4.95 g (30.0% yield) of compound **6**; Fraction II, 11.2 g (68% yield) of compound **7**. Compound **6** was a colorless solid (m.p. = 106--107 °C, MeOH/Et~2~O). IR (cm^−1^): 2947 (C-CH~3~); 2874 (C-CH~3~); 1743 (C=O); 1717 (C=O); 1689 (C=O); 1469 (CH~2~); 1383 (CH~3~); 1164 (C-O). ^1^H-NMR: 3.64 (s, 3H, CH~3~O); 2.63 (dd, *J* = 13.4 and 14.7 Hz, 1H, H-12); 0.93 (s, 3H, H-19); 0.91 (d, *J* = 6.5 Hz, 3H, H-21); 0.67 (s, 3H, H-18). ^13^C-NMR: See [Table 2](#molecules-21-01139-t002){ref-type="table"}. Compound **7** was a colorless solid (m.p. = 95--100 °C, MeOH/Et~2~O). IR (cm^−1^): 3301 (O-H); 2943 (C-CH~3~); 2867 (C-CH~2~-C); 2849 (C-CH~2~-C); 2828 (CH~3~O); 1740 (C=O); 1709 (C=O); 1436 (CH~2~); 1326 (CH~3~); 1171 (C-O). ^1^H-NMR: 3.66 (s, 3H, CH~3~O); 3.62 (m, 1H, H-3); 2.33 (ddd, *J* = 5, 10 and 15.2 Hz, 1H, H-23); 0.92 (d, *J* = 6.4 Hz, 3H, H-21); 0.83 (s, 3H, H-19); 0.64 (s, 3H, H-18). ^13^C-NMR: See [Table 2](#molecules-21-01139-t002){ref-type="table"}. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}.

*Methyl 3α-hydroxy-6-oxo-5β-cholan-24-oate* (***7***). A solution of compound **6** (4.95 g, 12.3 mmol) was prepared in 100 mL of MeOH. This solution was placed in a bath of ice-water between 0--5 °C. Subsequently 0.47 g (12.3 mmol) of NaBH~4~ were added in four portions (approximately 0.118 g each) maintaining the temperature and with slow stirring. The end of reaction was verified by TLC, so 20 mL of acetone and 5 mL of HCl 2.5% were added, maintaining the reaction temperature. The reaction mixture was concentrated by evaporation under reduced pressure to a volume of about 15 mL, and then AcOEt (50 mL) was added. The organic layer was washed with saturated solution of NaHCO~3~ (20 mL) and water (2 × 30 mL), dried over Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure. The crude was re-dissolved in CH~2~Cl~2~ (5 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 5.8:4.2) Two fractions were obtained: Fraction I, 2.88 g of unreacted compound **6**; Fraction II, 2.04 g (41.2%) of compound **7**. Later reduction with NaHB~4~/CH~3~OH at 0--5 °C of recovered compound **6** (2.88 g), produced 2.75 g of **7** with 95.5% yield. The total yield in both reductions for compound **7** was 96.8%. The physical and spectroscopic properties of compound **7** were identical to those reported above for oxidation of compound **5**. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}.

*Methyl 3α-hydroxy-6-oxo-5α-cholan-24-oate* (**8**). Compound **7** (4.79 g, 11.8 mmol) was dissolved in 100 mL of 2.5% *v/v* HCl-MeOH, at room temperature and constant agitation for 24 h. The end of reaction was verified by TLC. The solvent was evaporated under reduced pressure and the crude was re-dissolved in 40 mL of AcOEt. The organic layer was washed with saturated solution of NaHCO~3~ (30 mL) and water (2 × 30 mL), dried over Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure. The crude was re-dissolved in CH~2~Cl~2~ (5 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 6.0:4.0). Compound **8** (4.79 g, 94.4% yield) was a colorless solid (m.p. = 128--132 °C, MeOH/Et~2~O) IR (cm^−1^): 3302 (O-H); 2943 (C-CH~3~); 2867 (C-CH~2~-C); 2849 (C-CH~2~-C); 2828 (CH~3~O); 1740 (C=O); 1709 (C=O); 1436 (CH~2~); 1375 (CH~3~); 1257 (C-O); 1172 (C-O). ^1^H-NMR: 4.16 (m, 1H, H-3); 3.66 (s, 3H, CH~3~O); 2.70 (t, *J* = 7.9 Hz, 1H, H-5); 2.33 (ddd, *J* = 5.3, 10.3 and 15.5 Hz, 1H, H-23); 0.91 (d, *J* = 6.4 Hz, 3H, H-21); 0.72 (s, 3H, H-19); 0.65 (s, 3H, H-18). ^13^C-NMR: See [Table 2](#molecules-21-01139-t002){ref-type="table"}. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}.

*Methyl 3α-methanesulfonyl-6-oxo-5α-cholan-24-oate* (**9**). Compound **8** (1.00 g, 2.47 mmol) was dissolved in 20 mL of DCM, 5 mg of DMAP and 1 mL of pyridine were added, then the mixture was cooled to 0--5 °C. Later 1.0 mL (12.9 mmol) of CH~3~SO~2~Cl slowly was added with gentle agitation. The mixture was kept at 0 °C for 30 min and subsequently left at room temperature. The end of reaction was verified by TLC. The solvent was evaporated under reduced pressure and the crude was re-dissolved in 20 mL of AcOEt. The organic layer was washed with saturated solution of NaHCO~3~ (40 mL) and water (2 × 30 mL), dried over Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure. The crude was re-dissolved in CH~2~Cl~2~ (5 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 5.8:4.2). Two fractions were obtained: Fraction I, 726 mg (61.0% yield) of compound **9**, and Fraction II, 230 mg of unreacted compound **8**. Compound **9** was a colorless solid (m.p. = 129--131 °C, MeOH/Et~2~O) IR (cm^−1^): 2945 (C-CH~3~); 2867 (C-CH~2~-C); 1736 (C=O); 1709 (C=O); 1435 (CH~2~); 1351 (CH~3~); 1255 (C-O); 1171 (C-O). ^1^H-NMR: 5.02 (b.s, 1H, H-3); 3.64 (s, 3H, CH~3~O); 2.97 (s, 3H, CH~3~SO~3~); 2.60 (dd, *J* = 2.3 and 12.4 Hz, 1H, H-5); 0.901 (d, *J* = 6.4 Hz, 3H, H-21); 0.713 (s, 3H, H-19); 0.639 (s, 3H, H-18). ^13^C-NMR: See [Table 2](#molecules-21-01139-t002){ref-type="table"}. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}.

*Methyl 2-en-6-oxo-5α-cholan-24-oate* (**10**). To a solution of compound **9** (1.30 g, 0.269 mmol) in 40 mL of DMF, 200 mg Li~2~CO~3~ (2.71 mmol) and LiBr (235 mg, 2.71 mmol) were added. Then the reaction mixture was stirred and refluxed at 80 °C for 1.5 h. The end of reaction was verified by TLC, the mixture was then filtered and the mother liquor concentrated to a volume of approximately 15 mL under reduced pressure. Then AcOEt (30 mL) were added. The organic layer was washed with water (2 × 20 mL), dried over Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure and the crude was re-dissolved in CH~2~Cl~2~ (5 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 2.4:7.6). Compound **10** (0.900 g, 74.9% yield) was a colorless solid (m.p. = 67--69 °C, hexane/Et~2~O) IR (cm^−1^): 3020 (CH=); 2968 (CH~3~-); 2939 (CH~3~-); 2899 (C-CH~2~-C); 2867 (C-CH~2~-C); 1737 (C=O); 1703 (C=O); 1635 (C=C); 1435 (CH~2~); 1383 (CH~3~); 1250, (C-O); 1168 (C-O). ^1^H-NMR: 5.69--5.66 (m, 1H, H-3); 5.57--5.55 (m, 1H, H-2); 3.66 (s, 3H, CH~3~O); 0.924 (d, *J* = 6.4 Hz, 3H, H-21); 0.701 (s, 3H, H-19); 0.665 (s, 3H, H-18). ^13^C-NMR: See [Table 2](#molecules-21-01139-t002){ref-type="table"}. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}.

*Methyl 2α,3α-dihydroxy-6-oxo-5α-cholan-24-oate* (**11**). A solution of compound **10** (500 mg, 1.29 mmol) in 30 mL of acetone and 10 mL water was prepared. Later 10 mg of NMMNO, 2 mL 4.0% (0,314 mmol) OsO~4~ solution and 2 mL of pyridine were added. The mixture was kept under constant stirring at room temperature for 72 h. The end of reaction was verified by TLC, and then 25 mL of Na~2~S~2~O~3~ saturated solution were added and allowed to stir for 30 min. The reaction was concentrated to a volume of approximately 15 mL under reduced pressure. Then AcOEt (40 mL) were added. The organic layer was washed with water (2 × 25 mL), dried over anhydrous Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure and the crude was re-dissolved in CH~2~Cl~2~ (5 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 8.2:1.8). Two fractions were obtained: Fraction I, 218 mg of unreacted compound **10** and Fraction II, 277 mg (51.0% yield) of compound **11**. Compound **11** was a colorless solid (m.p. = 178--179 °C, MeOH/Et~2~O). IR (cm^−1^): 3392 (OH); 2944 (CH~3~-); 2867 (C-CH~2~-C); 1738 (C=O); 1709 (C=O); 1435 (CH~2~); 1376 (CH~3~); 1255, C-O); 1170 (C-O). ^1^H-NMR: 4.05 (b.s, 1H, H-3); 3.77 (b.d, *J* = 11.1 Hz, 1H, H-2); 3.66 (s, 3H, CH~3~O); 2.67 (dd, *J* = 3.0 and 12.6 Hz, 1H, H-5); 0.926 (d, *J* = 6.4 Hz, 3H, H-21); 0.752 (s, 3H, H-19); 0.659 (s, 3H, H-18). ^13^C-NMR: See [Table 2](#molecules-21-01139-t002){ref-type="table"}. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}.

*Methyl 3α-acetoxy-6-oxo-5α-cholan-24-oate* (**12**). To a solution of compound **8** (2.00g, 4.94 mmol) in 20 mL of DCM, 5 mg of DMAP, 1 mL of pyridine and 0.5 mL (5.3 mmol) of Ac~2~O were added. The reaction mixture was kept under constant stirring and room temperature for 30 min. The end of reaction was verified by TLC, the mixture was then concentrated to a volume approximately 5 mL under reduced pressure. Then AcOEt (30 mL) were added. The organic layer was washed with water (2 × 15 mL), dried over Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure and the crude was re-dissolved in CH~2~Cl~2~ (5 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 4.7:5.3). Compound **12** (1.9 g, 95% yield) was a colorless solid (m.p. = 174--176 °C, MeOH/Et~2~O) IR (cm^−1^): 2943 (CH~3~); 2869 (CH~2~); 1737 (C=O); 1708 (C=O); 1435 (CH~2~); 1376 (CH~3~); 1262 (C-O); 1221 (C-O); 1172 (C-O). ^1^H-NMR: 5.12 (m, 1H, H-3); 3.66 (s, 3H, CH~3~O); 2.56 (dd, *J* = 3.3 and 12.0 Hz, 1H, H-5); 2.38 (ddd, *J* = 5.4, 10.3 and 15.4 Hz, 1H, H-23); 2.04 (s, 3H, CH~3~CO); 0.94 (d, *J* = 6.4 Hz, 3H, H-21); 0.74 (s, 3H, H-19); 0.67 (s, 3H, H-18). ^13^C-NMR: See [Table 1](#molecules-21-01139-t001){ref-type="table"}. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}.

*Acid 3α-hydroxy-6-oxo-5α-cholan-24-oic* (**13**). A solution of compound **8** (5.0 g, 12.36 mmol) in 60 mL of MeOH was prepared. Later 20 mL of 15% *P/V* K~2~CO~3~ solution were added, and the reaction mixture was refluxed for 1 h. The end of reaction was verified by TLC, the mixture was then concentrated to a volume approximately 15 mL under reduced pressure. This was acidified with 20 mL of 10% HCl solution. Then AcOEt (40 mL) were added. The organic layer was washed with water (2 × 15 mL), dried over Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure and a colorless solid (4.11 g, 82.2% yield) was obtained. Compound **13** (m.p. = 102--107 °C, MeOH/Et~2~O) IR (cm^−1^): 3403--2500 (O-H); 2945 (CH~3~); 2869 (CH~2~); 1712 (C=O); 1689 (C=O); 1442 (CH~2~); 1380 (CH~3~). ^1^H-NMR (CD~3~OD): 4.04 (m, 1H, H-C3); 2.75 (t, *J* = 8.1 Hz, 1H, H-5); 2.31 (ddd, *J* = 5.3, 9.9 and 15.2 Hz, 1H, H-23); 0.96 (d, *J* = 6.5 Hz, 3H, H-21); 0.730 (s, 3H, H-19); 0.71 (s, 3H, H-18). ^13^C-NMR: See [Table 1](#molecules-21-01139-t001){ref-type="table"}. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}.

*Acid 3α-acetoxy-6-oxo-5α-cholan-24-oic* (**14**). To a solution of compound **13** (5.0 g, 12.8 mmol) in 60 mL of DCM, 10 mg of DMAP, 1 mL of pyridine and 1.2 mL (12.8 mmol) of Ac~2~O were added. The reaction mixture was kept under constant stirring and room temperature for 1 h. The end of reaction was verified by TLC, the mixture was then concentrated to a volume approximately 10 mL under reduced pressure. Then AcOEt (40 mL) were added. The organic layer was washed with 5% HCl (1 × 10 mL), water (2 × 15 mL), dried over Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure and the crude was re-dissolved in CH~2~Cl~2~ (5 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 8.8:11.2). Compound **14** (3.64 g, 72.8% yield) was a colorless solid (m.p. = 171--177 °C, MeOH/Et~2~O) IR (cm^−1^): 3373-2495 (O-H); 2947 (CH~3~); 2869 (CH~2~); 1736 (C=O); 1708 (C=O); 1444 (CH~2~); 1376 (CH~3~). ^1^H-NMR: 5.12 (m, 1H, H-3); 2.56 (dd, *J* = 3.3 and 12.0 Hz, 1H, H-5); 2.38 (ddd, *J* = 5.4, 10.3 and 15.4 Hz, 1H, H-23); 2.03 (s, 3H, CH~3~CO); 0.94 (d, *J* = 6.4 Hz, 3H, H-21); 0.74 (s, 3H, H-19); 0,67 (s, 3H, H-18). ^13^C-NMR: See [Table 1](#molecules-21-01139-t001){ref-type="table"}. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}.

*Methyl 3α-hydroxy-6-oxo-7-oxa-5α-cholan-24-oate* (**15**) and *methyl 3α-hydroxy-6-oxa-7-oxo-5α-cholan-24-oate* (**16**). To a solution of **8** (100 mg, 0.247 mmol) in 60 mL of DCM, 55.3 mg (0.320 mmol) of *m*-CPBA (77%) and 269 mg (0.320 mmol) of NaHCO~3~ were added and the mixture was stirred at room temperature by 24 h. The end of reaction was verified by TLC, the mixture was filtered then concentrated to a volume approximately 5 mL under reduced pressure. Then AcOEt (40 mL) were added. The organic layer was washed with saturated NaHCO~3~ solution (2 × 20 mL), water (2 × 15 mL), dried over Na~2~SO~4~, and filtered. The solvent was evaporated under reduced pressure and the crude was re-dissolved in CH~2~Cl~2~ (5 mL) and chromatographed on silica gel with EtOAc/hexane mixtures of increasing polarity (0.2:9.8 → 6.0:4.0) Three fractions were obtained. Fraction I: 37 mg of unreacted compound **8**. Fraction II: 11.2 mg (10.8% yield) of compound **15** and Fraction III: 15.5 mg (14.9% yield) of compound **16**. Compound **15** was a colorless solid (m.p. = 140--142 °C, MeOH/Et~2~O) IR (cm^−1^): 3446 (O-H); 2947 (C-CH~3~); 2871 (C-CH~2~-C); 2849 (C-CH~2~-C); 1732 (C=O); 1436 (CH~2~); 1373 (CH~3~); 1251 (C-O); 1168 (C-O). ^1^H-NMR: 4.15 (b.s. 1H, H-3); 4.08-4.06 (m, 2H, H-7); 3.66 (s, 3H, CH~3~O); 3.17 (dd, *J* = 4.4 and 12.2 Hz, 1H, H-5); 0.907 (d, *J* = 6.5 Hz, 3H, H-21); 0.878 (s, 3H, H-19); 0.700 (s, 3H, H-18). ^13^C-NMR: See [Table 1](#molecules-21-01139-t001){ref-type="table"}. Compound **16** was a colorless solid (m.p. = 155--157 °C). IR (cm^−1^): 3446 (O-H); 2946 (C-CH~3~); 1732 (C=O); 1444 (CH~2~); 1377 (CH~3~); 1250 (C-O); 1166 (C-O). ^1^H-NMR: 4.60 (dd, *J* = 5.3 and 11.3 Hz, 1H, H-5); 4.20 (b.s. 1H, H-3); 3.65 (s, 3H, CH~3~O); 0.897 (d, *J* = 6.6 Hz, 3H, H-21); 0.878 (s, 3H, H-19); 0.678 (s, 3H, H-18). ^13^C-NMR: See [Table 1](#molecules-21-01139-t001){ref-type="table"}. ^1^H-NMR and ^13^C-NMR are shown in [Supplementary Materials](#app1-molecules-21-01139){ref-type="app"}

4. Conclusions {#sec4-molecules-21-01139}
==============

An improved synthesis of known brassinosteroid analogues 7-oxalactone **15**, 6-oxalactone **16** and the 2α,3α-diol **11** from hyodeoxycholic acid has been described (**4**). These compounds and intermediates were obtained through modification of hyodeoxycholic acid as described previously. In the alternative procedure described here, the co-product **6** obtained in the oxidation of methyl hyodeoxycholate **5** was converted into the target monoketone **7** by stereoselective reduction with NaBH~4~, increasing the overall yield of this synthetic route to 96.8%.

Additionally, using mono- and bi-dimensional NMR techniques, we have updated the ^1^H-NMR spectroscopic information for derivatives of hyodeoxycholic acid **5**--**16**, and a complete assignment of all ^13^C-NMR signals has also been made.

Derivatives **8**, **13** and **14** will be used in the synthesis of new brassinosteroid analogues, while derivatives **8**, **11**, **15** and **16** will be evaluated as plant-growth regulators in the Rice Lamina Inclination Assay and for antifungal activity in plants. These results will be reported later.
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![Structure of bile acids used for the synthesis of brassinolide and its analogues.](molecules-21-01139-g001){#molecules-21-01139-f001}

![Synthesis of hyodeoxycholic acid derivatives **5**--**10** and brassinosteroid analogue **11**. *Reagents and conditions*: (**a**) CH~3~OH/H~2~SO~4~, reflux, 2 h; (**b**) PCC/DCM, 48 h., r.t., C.C. separation; (**c**) NaBH~4~/MeOH, 0--5 °C, 1 h; (**d**) HCl/CH~3~OH 2.5%, r.t., 24 h; (**e**) CH~3~SO~2~Cl/DCM, DMAP, 0 °C ≥ r.t. 1 h; (**f**) Li~2~CO~3~/LiBr, DMF, 80 °C, 1.5 h; (**g**) OsO~4~ 4%/NMO, acetone, r.t., 72 h.](molecules-21-01139-sch001){#molecules-21-01139-sch001}

![Major differences observed in the ^1^H- and ^13^C-NMR data of compounds **7** and **8**, associated with the change from the 5β-cholestan to 5α-cholestan skeleton (A/B ring *cis* for *trans* fusion).](molecules-21-01139-g002){#molecules-21-01139-f002}

![Synthesis of hyodeoxycholic acid derivatives **8**, **12**--**14** and known 7-oxalactone **15** and 6-oxalactone **16**. *Reagents and conditions*: (**a**) Ac~2~O/DMAP, CH~2~Cl~2~/py, r.t., 30 min; (**b**) K~2~CO~3~/CH~3~OH, reflux, 1 h; (**c**) *m*-CPBA/CH~2~Cl~2~, NaHCO~3~ r.t., 24 h.](molecules-21-01139-sch002){#molecules-21-01139-sch002}

###### 

(**a**) Inverse detection heteronuclear-correlated 2D ^1^H-^13^C HMBC contour plot and major observed ^2^*J*~HC~ and ^3^*J*~HC~ correlations for H-5α in 7-oxalactone **15** and (**b**) for 6-oxolactone **16**.

![](molecules-21-01139-g003a)

![](molecules-21-01139-g003b)
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###### 

Chemical shifts, δ, of ^13^C-NMR (CDCl~3~, 100.6 MHz) for compounds **12**--**16**.

  C                 12       13 \*    14       15       16
  ----------------- -------- -------- -------- -------- --------
  1                 32.38    32.87    32.36    32.88    27.46
  2                 27.89    28.96    27.88    22.13    30.75
  3                 68.87    66.01    68.85    64.88    66.31
  4                 25.26    28.70    25.28    30.81    35.63
  5                 52.58    52.83    52.56    41.78    79.65
  6                 211.86   215.65   211.84   176.76   175.35
  7                 46.71    47.59    46.73    70.44    38.07
  8                 37.91    39.41    37.93    39.45    35.27
  9                 53.73    55.03    53.72    58.35    57.97
  10                41.26    43.71    41.24    36.29    39.85
  11                21.06    22.17    21.09    24.80    22.17
  12                39.44    40.78    39.47    39.68    39.66
  13                43.02    44.16    43.07    42.66    42.71
  14                55.79    57.18    55.76    55.72    56.00
  15                25.00    28.42    25.00    28.23    25.24
  16                23.88    24.92    23.87    27.82    27.93
  17                56.74    57.89    56.75    51.45    55.48
  18                12.01    12.41    12.01    11.79    11.78
  19                12.39    12.68    12.40    14.51    11.53
  20                35.24    36.60    35.25    35.31    34.83
  21                18.19    18.72    18.17    18.14    18.12
  22                30.67    32.01    30.65    31.01    30.99
  23                30.84    32.24    30.83    32.49    31.15
  24                174.67   178.19   179.20   174.60   174.64
  CH~3~O            51.45    \-       \-       51.50    51.52
  CH~3~[C]{.ul}O-   170.31   \-       170.33   \-       \-
  [C]{.ul}H~3~CO-   21.39    \-       21.41    \-       \-

\* The ^13^C-NMR spectrum of compound **13** was recorded in CD~3~OD solution.
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###### 

Chemical shifts, δ, of ^13^C-RMN (CDCl~3~, 100.6 MHz) for compounds **5**--**11**.

  C         5        6        7        8        9        10       11
  --------- -------- -------- -------- -------- -------- -------- --------
  **1**     35.56    35.71    34.37    31.65    27.80    39.34    40.18
  **2**     29.20    36.42    34.86    28.16    31.64    124.49   68.29
  **3**     71.48    208.58   70.15    65.41    78.71    124.95   68.39
  **4**     34.86    39.83    29.85    27.90    26.56    27.88    26.28
  **5**     48.40    59.67    59.40    51.65    51.78    53.35    50.69
  **6**     67.98    210.75   213.88   212.70   211.08   211.96   214.15
  **7**     30.11    42.08    37.97    46.83    46.52    46.95    46.73
  **8**     34.79    36.61    37.06    37.94    37.79    37.67    35.65
  **9**     39.81    40.83    39.60    53.77    53.35    53.82    53.66
  **10**    35.90    38.22    39.99    41.53    40.99    40.00    42.98
  **11**    20.72    21.23    20.83    21.03    20.94    21.08    21.17
  **12**    39.92    39.41    42.91    39.45    39.25    39.44    39.35
  **13**    42.80    43.02    43.09    42.89    42.90    42.84    42.55
  **14**    55.89    55.74    55.79    55.71    56.58    56.69    56.61
  **15**    28.10    27.88    27.98    27.67    51.79    53.35    23.91
  **16**    24.17    23.85    23.96    23.88    23.79    21.70    27.91
  **17**    56.14    56.70    56.82    56.73    55.62    55.75    55.69
  **18**    11.98    11.92    11.96    12.00    11.92    11.92    12.01
  **19**    23.48    22.40    23.16    12.29    12.39    13.48    13.55
  **20**    35.32    35.19    35.28    35.29    35.19    35.29    35.30
  **21**    18.21    18.18    18.23    18.21    18.13    18.23    18.22
  **22**    30.91    30.80    30.90    30.89    30.79    30.90    31.04
  **23**    31.02    30.95    31.05    31.03    30.94    31.03    30.89
  **24**    174.71   174.50   174.67   174.67   174.56   174.64   174.72
  CH~3~O-   51.48    51.44    51.52    51.50    51.42    51.49    51.54
  MsO-      \-       \-       \-       \-       38.38    \-       \-
